Fasciola gigantica: The in vitro effects of artesunate as compared to triclabendazole on the 3-weeks-old juvenile

► Triclabendazole (TCZ), artesunate (ATS) reduced motility of 3-week Fasciola gigantica. ► ATS disrupt tegument by affecting tegumental surface membrane and mitochondria. ► ATS caused disruption of cytoskeleton and vacuolization of the tegument.